CASR and nephrolithiasis: However, our studies indicate that increased serum calcium concentrations may have an underappreciated role in KSD that is independent of urinary calcium excretion, and that the use of negative CaSR allosteric modulators, which would be expected to increase serum calcium concentrations, may increase the risk of kidney stones.